Long lasting facial rejuvenation by repeated placement of calcium hydroxylapatite in elderly women.
calcium hydroxylapatite
elderly women
facial rejuvenation
filler injections
long-lasting efficacy
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
10
07
2020
revised:
20
07
2020
accepted:
07
08
2020
pubmed:
15
8
2020
medline:
15
5
2021
entrez:
15
8
2020
Statut:
ppublish
Résumé
Calcium hydroxylapatite (CaHA) is a biostimulatory filler with long lasting efficacy after a single injection. Data con the effect of repeated injections, however, are sparse. This is a single-center observational study. Forty Caucasian females of Fitzpatrick skin type I to III, aged between 50 and 95 years (mean age 63 ± 13.4 years), and seeking nonsurgical improvement of facial aging were included. Patients with previous face lifts, threads or other surgical treatments were excluded. Only women ≥50 years of age were included. Midface and lower face were treated, that is, cheeks, tear troughs, jawline, and Marionette lines. The usual time for a repetition of filler injection was 12 to 14 months. Mean follow-up was 36 ± 10.8 months after first injection of Radiesse. Outcome was measured using the Global Aesthetic Improvement Scale (GAIS). Mean patient's GAIS was 2.7 ± 0.7, while physicians GAIS was 2.6 ± 0.6 suggesting a remarkable improvement 12 months after the first procedure. Mean patient's GAIS at 3 and 5 years after first procedure was 2.4 ± 0.8, while physicians GAIS was 2.5 ± 0.7. Repeated injection of CaHA leads to a significant and long-lasting improvement of facial appearance.
Substances chimiques
Durapatite
91D9GV0Z28
Calcium
SY7Q814VUP
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14183Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Misiek DJ, Kent JN, Carr RF. Soft tissue responses to hydroxylapatite particles of different shapes. J Oral Maxillofac Surg. 1984;42(3):150-160.
Drobeck HP, Rothstein SS, Gumaer KI, Sherer AD, Slighter RG. Histologic observation of soft tissue responses to implanted, multifaceted particles and discs of hydroxylapatite. J Oral Maxillofac Surg. 1984;42(3):143-149.
Pettis GY, Kaban LB, Glowacki J. Tissue response to composite ceramic hydroxyapatite/demineralized bone implants. J Oral Maxillofac Surg. 1990;48(10):1068-1074.
Hobar PC, Pantaloni M, Byrd HS. Porous hydroxyapatite granules for alloplastic enhancement of the facial region. Clin Plast Surg. 2000;27(4):557-569.
Havlik RJ, PSEF DATA Committee. Hydroxyapatite. Plast Reconstr Surg. 2002;110(4):1176-1179.
Wollina U, Wiegand C, Hipler UC. Calcium hydroxylapatite microspheres - biocompatibility and clinical effects. Georgian Med News. 2018;278:62-68.
Rosamilia G, Hamade H, Freytag DL, et al. Soft tissue distribution pattern of facial soft tissue fillers with different viscoelastic properties. J Cosmet Dermatol. 2020;19(2):312-320.
Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications [published correction appears in Plast Reconstr Surg. 2013 Nov;132(5):1378]. Plast Reconstr Surg. 2013;132(4 Suppl 2):5S-21S.
Pavicic T. Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study. Clin Cosmet Invest Dermatol. 2015;8:19-25.
Coleman KM, Voigts R, DeVore DP, et al. Neocollagenesis after injection of calcium hydroxylapatite composition in a canine model. Dermatol Surg. 2008;34(suppl 1):S53-S55.
Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34(Suppl 1):S64-S67.
Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther. 2004;6(4):223-226.
Yutskovskaya YA, Kogan EA. Improved neocollagenesis and skin mechanical properties after injection of diluted calcium hydroxylapatite in the neck and décolletage: a pilot study. J Drugs Dermatol. 2017;16:68-74.
Yutskovskaya Y, Kogan E, Leshunov E. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. J Drugs Dermatol. 2014;13:47-52.
Zerbinati N, Calligaro A. Calcium hydroxylapatite treatment of human skin: evidence of collagen turnover through picrosirius red staining and circularly polarized microscopy. Clin Cosmet Invest Dermatol. 2018;11:29-35.
Kadouch JA. Calcium hydroxylapatite: a review on safety and complications. J Cosmet Dermatol. 2017;16(2):152-161.
Wollina U. Improvement of tear trough by monophasic hyaluronic acid and calcium hydroxylapatite. J Clin Aesthet Dermatol. 2014;7(10):38-43.
Wollina U. Facial rejuvenation starts in the midface: three-dimensional volumetric facial rejuvenation has beneficial effects on nontreated neighboring esthetic units. J Cosmet Dermatol. 2016;15(1):82-88.
Wollina U, Goldman A. Minimal invasive chin and jawline improvement in women in the second half of their life. Dermatol Ther. 2020;33(3):e13320.
Hersant B, Abbou R, SidAhmed-Mezi M, Meningaud JP. Assessment tools for facial rejuvenation treatment: a review. Aesthetic Plast Surg. 2016;40(4):556-565.
Muti GF. Open-label, post-marketing study to evaluate the performance and safety of calcium Hydroxylapatite with integral lidocaine to correct facial volume loss. J Drugs Dermatol. 2019;18(1):86-91.
Lorenc ZP, Bass LM, Fitzgerald R, Goldberg DJ, Graivier MH. Composite facial Volumization with calcium Hydroxylapatite (CaHA) for the treatment of aging. Aesthet Surg J. 2018;38(suppl 1):S18-S23.
Simunovic F, Schlager S, Montanari M, Iblher N. Prospective 3D analysis of facial soft tissue augmentation with calcium hydroxylapatite. J Cosmet Laser Ther. 2017;19(5):283-289.
Tzikas TL. Evaluation of the radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg. 2004;6(4):234-239.
Jacovella PF, Peiretti CB, Cunille D, Salzamendi M, Schechtel SA. Long-lasting results with hydroxylapatite (Radiesse) facial filler. Plast Reconstr Surg. 2006;118(3 Suppl):15S-21S.
Moers-Carpi M, Storck R, Howell DJ, Ogilvie P, Ogilvie A. Physician and patient satisfaction after use of calcium hydroxylapatite for cheek augmentation. Dermatol Surg. 2012;38(7 Pt 2):1217-1222.
Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J. 2010;30(2):235-238.
Fakhre GP, Perdikis G, Shaddix KK, Terkonda SP, Waldorf JC. An evaluation of calcium hydroxylapatite (Radiesse) for cosmetic nasolabial fold correction: a meta-analysis and patient centric outcomes study. Ann Plast Surg. 2009;63(5):486-489.
Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006;118(3 Suppl):22S-33S.
Wollina U. Midfacial rejuvenation by hyaluronic acid fillers and subcutaneous adipose tissue - a new concept. Med Hypotheses. 2015;84(4):327-330.
Kruglikov IL, Wollina U. Soft tissue fillers as non-specific modulators of adipogenesis: change of the paradigm? Exp Dermatol. 2015;24(12):912-915.
Wollina U, Wetzker R, Abdel-Naser MB, Kruglikov IL. Role of adipose tissue in facial aging. Clin Interv Aging. 2017;12:2069-2076.
Yoo G, Lim JS. Tissue engineering of injectable soft tissue filler: using adipose stem cells and micronized acellular dermal matrix. J Korean Med Sci. 2009;24(1):104-109.
Nowacki M, Pietkun K, Pokrywczyńska M, et al. Filling effects, persistence, and safety of dermal fillers formulated with stem cells in an animal model. Aesthet Surg J. 2014;34(8):1261-1269.